ACM Research Cl A saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 80 to 84.
This proprietary rating identifies market leadership by using a 1 (worst) to 99 (best) score that identifies how a stock's price action over the last 52 weeks matches up against other publicly traded companies.
Over 100 years of market history reveals that the stocks that go on to make the biggest gains often have an 80 or better RS Rating in the early stages of their moves.
Looking For The Best Stocks To Buy And Watch? Start Here
ACM Research Cl A is working on a cup without handle with a 26.32 entry. See if the stock can break out in heavy volume. Note that it's a third-stage base. Such later-stage patterns involve more risk and are more and have a higher likelihood to fail than first- or second-stage consolidations.
The company reported 11% earnings growth in the latest quarterly report, while sales growth came in at 21%. The next quarterly results are expected on or around Feb. 26.
The company earns the No. 3 rank among its peers in the Electronics-Semiconductor Equipment industry group. Nova is the top-ranked stock within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
